Document Detail

Therapeutic myocardial angiogenesis.
MedLine Citation:
PMID:  17950369     Owner:  NLM     Status:  MEDLINE    
Armed with an improved understanding of the mediators of angiogenesis, physicians and scientists have made significant efforts at harnessing this naturally occurring process in order to treat patients with a variety of peripheral vascular and coronary ischemic syndromes. There is a growing population of patients with end-stage coronary artery disease (CAD) who are no longer candidates for mechanical revascularization, yet suffer from chronic myocardial ischemia who may benefit from regeneration of the depleted microvasculature.
Marie-Ange Renault; Douglas W Losordo
Related Documents :
8465739 - Identification of high-risk patients with left main and three-vessel coronary artery di...
17653519 - Increased prevalence of ventricular fibrillation in patients with type 2 diabetes melli...
19615769 - Left atrial volume and index by multi-detector computed tomography: comprehensive analy...
9605599 - Benefits of combination therapy in hypertensive patients with associated coronary arter...
2662729 - Antianginal and cardiac metabolic effects of low-dose glucose infusion during pacing in...
23741389 - Ictal modulation of cardiac repolarization, but not of heart rate, is lateralized in me...
9708469 - Efficacy of augmented immunosuppressive therapy for early vasculopathy in heart transpl...
14566249 - Association of lipoprotein(a) excess with early vein graft occlusions in middle-aged me...
10509239 - Predictive value of regional left ventricular circumferential shortening in jeopardized...
Publication Detail:
Type:  Journal Article; Review     Date:  2007-09-07
Journal Detail:
Title:  Microvascular research     Volume:  74     ISSN:  0026-2862     ISO Abbreviation:  Microvasc. Res.     Publication Date:    2007 Sep-Nov
Date Detail:
Created Date:  2007-11-12     Completed Date:  2008-01-08     Revised Date:  2014-09-18    
Medline Journal Info:
Nlm Unique ID:  0165035     Medline TA:  Microvasc Res     Country:  United States    
Other Details:
Languages:  eng     Pagination:  159-71     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Angiogenesis Inducing Agents / pharmacology*,  therapeutic use*
Cell- and Tissue-Based Therapy / methods
Clinical Trials, Phase I as Topic
Clinical Trials, Phase II as Topic
Gene Transfer Techniques
Genetic Therapy / methods
Myocardial Ischemia / drug therapy*
Myocardial Revascularization / methods*
Neovascularization, Physiologic / physiology
Grant Support
R01 HL057516/HL/NHLBI NIH HHS; R01 HL057516-05/HL/NHLBI NIH HHS; R01 HL057516-06/HL/NHLBI NIH HHS; R01 HL057516-07/HL/NHLBI NIH HHS; R01 HL057516-08/HL/NHLBI NIH HHS; R01 HL057516-09/HL/NHLBI NIH HHS; R01 HL057516-10/HL/NHLBI NIH HHS; R01 HL057516-11/HL/NHLBI NIH HHS; R01 HL063414/HL/NHLBI NIH HHS; R01 HL063414-01/HL/NHLBI NIH HHS; R01 HL063414-02/HL/NHLBI NIH HHS; R01 HL063414-03/HL/NHLBI NIH HHS; R01 HL063414-04/HL/NHLBI NIH HHS; R01 HL063414-05A1/HL/NHLBI NIH HHS; R01 HL063414-06/HL/NHLBI NIH HHS; R01 HL063414-07/HL/NHLBI NIH HHS; R01 HL063414-08/HL/NHLBI NIH HHS; R01 HL077428/HL/NHLBI NIH HHS; R01 HL077428-01A2/HL/NHLBI NIH HHS; R01 HL077428-02/HL/NHLBI NIH HHS; R01 HL080137/HL/NHLBI NIH HHS; R01 HL080137-01A1/HL/NHLBI NIH HHS; R01 HL080137-02/HL/NHLBI NIH HHS
Reg. No./Substance:
0/Angiogenesis Inducing Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Potential therapeutic strategies for lymphatic metastasis.
Next Document:  Similarities between angiogenesis and neural development: what small animal models can tell us.